Russell Investments Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $6.92K | Buy |
|
|||||
|
2024
Q3 | $1.03K | Sell |
|
|||||
|
2024
Q2 | $522 | Buy |
|
|||||
|
2024
Q1 | $822 | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $2.09K | Sell |
|
|||||
|
2023
Q2 | $1.49M | Buy |
|
|||||
|
2023
Q1 | $915K | Sell |
|
|||||
|
2022
Q4 | $1.47M | Sell |
|
|||||
|
2022
Q3 | $4.16M | Buy |
|
|||||
|
2022
Q2 | $490K | Sell |
|
|||||
|
2022
Q1 | $775K | Sell |
|
|||||
|
2021
Q4 | $840K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $172K | Hold |
|
|||||
|
2021
Q1 | $163K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.31M | Buy |
|
|||||
|
2020
Q2 | $902K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $155K | Sell |
|
|||||
|
2019
Q2 | $396K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $174K | Buy |
|